Trial record 1 of 1 for:    Cytarabine and Lenalidomide AND Buffalo
Previous Study | Return to List | Next Study

Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

This study is currently recruiting participants.
Verified March 2014 by Roswell Park Cancer Institute
Celgene Corporation
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: November 12, 2010
Last updated: March 25, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)